178 related articles for article (PubMed ID: 34340981)
21. Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.
Salvagno GL; Henry BM; Pighi L; De Nitto S; Gianfilippi GL; Lippi G
J Infect; 2021 Aug; 83(2):e4-e5. PubMed ID: 34214516
[No Abstract] [Full Text] [Related]
22. Response to: 'Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'' by Smerilli
Priori R; Pellegrino G; Colafrancesco S; Alessandri C; Ceccarelli F; Di Franco M; Riccieri V; Scrivo R; Sili Scavalli A; Spinelli FR; Conti F
Ann Rheum Dis; 2021 Oct; 80(10):e169. PubMed ID: 33962963
[No Abstract] [Full Text] [Related]
23. SARS CoV-2 vaccine AND rituximab. Comment on: "SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response" by Verhoeven Joint Bone Spine. 2021;88:105258.
Mungmunpuntipantip R; Wiwanitkit V
Joint Bone Spine; 2022 Jan; 89(1):105281. PubMed ID: 34600149
[No Abstract] [Full Text] [Related]
24. Response to: 'Correspondence on 'SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease'' by C
D'Silva KM; Serling-Boyd N; Hsu TY; Sparks JA; Wallace ZS
Ann Rheum Dis; 2023 Jun; 82(6):e131. PubMed ID: 33692020
[No Abstract] [Full Text] [Related]
25. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
[TBL] [Abstract][Full Text] [Related]
26. Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses.
Bitoun S; Avouac J; Henry J; Ghossan R; Al Tabaa O; Belkhir R; Nocturne G; Mariaggi AA; Rozenberg F; Vauloup-Fellous C; Mariette X; Seror R
RMD Open; 2022 May; 8(1):. PubMed ID: 35589332
[No Abstract] [Full Text] [Related]
27. Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia.
Lyski ZL; Kim MS; Xthona Lee D; Raué HP; Raghunathan V; Griffin J; Ryan D; Brunton AE; Curlin ME; Slifka MK; Messer WB; Spurgeon SE
Blood Adv; 2022 Feb; 6(4):1207-1211. PubMed ID: 34872103
[No Abstract] [Full Text] [Related]
28. Professionally responsible COVID-19 vaccination counseling-response to Chervenak et al.
Habiba M
Am J Obstet Gynecol; 2021 Sep; 225(3):355. PubMed ID: 34116034
[No Abstract] [Full Text] [Related]
29. A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice.
de Alwis R; Gan ES; Chen S; Leong YS; Tan HC; Zhang SL; Yau C; Low JGH; Kalimuddin S; Matsuda D; Allen EC; Hartman P; Park KJ; Alayyoubi M; Bhaskaran H; Dukanovic A; Bao Y; Clemente B; Vega J; Roberts S; Gonzalez JA; Sablad M; Yelin R; Taylor W; Tachikawa K; Parker S; Karmali P; Davis J; Sullivan BM; Sullivan SM; Hughes SG; Chivukula P; Ooi EE
Mol Ther; 2021 Jun; 29(6):1970-1983. PubMed ID: 33823303
[TBL] [Abstract][Full Text] [Related]
30. A lymph node-targeted Amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2.
Steinbuck MP; Seenappa LM; Jakubowski A; McNeil LK; Haqq CM; DeMuth PC
Sci Adv; 2021 Feb; 7(6):. PubMed ID: 33547083
[TBL] [Abstract][Full Text] [Related]
31. [Vaccination against SARS-CoV-2 in patients with multiple sclerosis].
Costa Frossard-França L; García-Domínguez JM; Moreno-Torres I; Fortún J; Villar LM; Meca-Lallana V
Rev Neurol; 2021 Apr; 72(7):250-260. PubMed ID: 33764494
[TBL] [Abstract][Full Text] [Related]
32. Mix-and-match COVID vaccines trigger potent immune response.
Callaway E
Nature; 2021 May; 593(7860):491. PubMed ID: 34012131
[No Abstract] [Full Text] [Related]
33. Humoral Immunity After mRNA SARS-CoV-2 Vaccination in Allogeneic HCT Recipients-Room for Improvement and Much to Learn.
Hill JA
JAMA Netw Open; 2021 Sep; 4(9):e2127454. PubMed ID: 34519771
[No Abstract] [Full Text] [Related]
34. Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series.
Danese E; Montagnana M; Salvagno GL; Peserico D; Pighi L; De Nitto S; Henry BM; Porru S; Lippi G
Clin Chem Lab Med; 2021 Aug; 59(9):1585-1591. PubMed ID: 33838087
[TBL] [Abstract][Full Text] [Related]
35. Re: "Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2" by Krsak
Mungmunpuntipantip R; Wiwanitkit V
Viral Immunol; 2021 Oct; 34(8):582. PubMed ID: 34491120
[No Abstract] [Full Text] [Related]
36. SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients.
Deng Y; Li Y; Yang R; Tan W
Cell Mol Immunol; 2021 Aug; 18(8):2040-2041. PubMed ID: 34267334
[No Abstract] [Full Text] [Related]
37. DNA vaccine protection against SARS-CoV-2 in rhesus macaques.
Yu J; Tostanoski LH; Peter L; Mercado NB; McMahan K; Mahrokhian SH; Nkolola JP; Liu J; Li Z; Chandrashekar A; Martinez DR; Loos C; Atyeo C; Fischinger S; Burke JS; Slein MD; Chen Y; Zuiani A; Lelis FJN; Travers M; Habibi S; Pessaint L; Van Ry A; Blade K; Brown R; Cook A; Finneyfrock B; Dodson A; Teow E; Velasco J; Zahn R; Wegmann F; Bondzie EA; Dagotto G; Gebre MS; He X; Jacob-Dolan C; Kirilova M; Kordana N; Lin Z; Maxfield LF; Nampanya F; Nityanandam R; Ventura JD; Wan H; Cai Y; Chen B; Schmidt AG; Wesemann DR; Baric RS; Alter G; Andersen H; Lewis MG; Barouch DH
Science; 2020 Aug; 369(6505):806-811. PubMed ID: 32434945
[TBL] [Abstract][Full Text] [Related]
38. SARS CoV-2 vaccine AND rituximab, timing might be a key for a better vaccine response.
Verhoeven F; Lepiller Q; Hecquet S; Prati C; Wendling D
Joint Bone Spine; 2021 Dec; 88(6):105258. PubMed ID: 34481943
[No Abstract] [Full Text] [Related]
39. SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris.
Fenizia C; Moltrasio C; Ottobrini L; Utyro O; Genovese G; Vanetti C; Trabattoni D; Marzano AV
J Invest Dermatol; 2023 Aug; 143(8):1601-1604. PubMed ID: 36716924
[No Abstract] [Full Text] [Related]
40. [Immunity against SARS-CoV-2: walking to the vaccination].
Rodríguez Hernández C; Sanz Moreno L
Rev Esp Quimioter; 2020 Dec; 33(6):392-398. PubMed ID: 32935536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
